Kumar, A., Casulo, C., Yahalom, J., Schöder, H., Barr, P. M., Caron, P., . . . Moskowitz, C. H. (2016). Brentuximab vedotin and AVD followed by involved-site radiotherapy in early stage, unfavorable risk Hodgkin lymphoma. Blood.
Citação norma ChicagoKumar, Anita, et al. "Brentuximab Vedotin and AVD Followed By Involved-site Radiotherapy in Early Stage, Unfavorable Risk Hodgkin Lymphoma." Blood 2016.
MLA CitationKumar, Anita, et al. "Brentuximab Vedotin and AVD Followed By Involved-site Radiotherapy in Early Stage, Unfavorable Risk Hodgkin Lymphoma." Blood 2016.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.